Generic Drug Utilization Substantially Lessens Medicare Part D Costs, OIG Reports
Projections estimated that the Medicare Part D drug program in 2006 would cost the federal government approximately $59 billion dollars. However, according to a report released just over a week ago by the United States Department of Health and Human Services, Office of Inspector General, actual costs for 2006 came in surprisingly low at $47 billion dollars--that's right--$12 billion dollars less than the estimates.
So, what accounts for the discrepancy?
According to the report, generic drug utilization makes up the difference. Generic drugs cost about 71% less than their brand name equivalents.
Continue Reading...